Clinical trial / 2015
Fenugreek powder supplementation significantly reduced the cumulative incidence of type 2 diabetes in people with prediabetes over 3 years.
A 3-year randomized controlled trial evaluated the efficacy of fenugreek powder (5 g twice daily before meals) compared to controls in 140 adults with prediabetes. By the end of the intervention, the cumulative incidence rate of diabetes was significantly reduced in the fenugreek group, with controls having a 4.2 times higher chance of developing diabetes. The fenugreek group also experienced significant reductions in fasting plasma glucose, postprandial plasma glucose, and LDL cholesterol, alongside a significant increase in serum insulin. In the fenugreek group, diabetes outcome was positively associated with serum insulin and negatively associated with insulin resistance (HOMA IR).
- Study type
- 3-year randomized, controlled, parallel study
- Who was studied
- 140 men and women aged 30-70 years with prediabetes (66 fenugreek, 74 controls)
- What was measured
- Progression to type 2 diabetes mellitus, FPG, PPPG, LDLc, serum insulin, and HOMA IR
THE PAPER
Role of Fenugreek in the prevention of type 2 diabetes mellitus in prediabetes.
Gaddam A, Galla C, Thummisetti S, Marikanty RK, Palanisamy UD, Rao PV. J Diabetes Metab Disord, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.